Burden of nonalcoholic fatty liver disease in Canada, 2019–2030: a modelling study

MG Swain, A Ramji, K Patel, G Sebastiani… - … Open Access Journal, 2020 - cmajopen.ca
Background: Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis
(NASH) account for a growing proportion of liver disease cases, and there is a need to better …

Nonalcoholic fatty liver disease burden: Australia, 2019–2030

LA Adams, SK Roberts, SI Strasser… - Journal of …, 2020 - Wiley Online Library
Abstract Background and Aim Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic
steatohepatitis (NASH) account for a large and growing proportion of liver disease burden …

Modelling NAFLD disease burden in four Asian regions—2019‐2030

C Estes, HLY Chan, RN Chien… - Alimentary …, 2020 - Wiley Online Library
Background Non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis
(NASH) account for an increasing proportion of liver disease in the Asia‐Pacific region …

[HTML][HTML] Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030

C Estes, QM Anstee, MT Arias-Loste, H Bantel… - Journal of …, 2018 - Elsevier
Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …

[PDF][PDF] Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

C Estes, H Razavi, R Loomba, Z Younossi… - …, 2018 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH)
are highly prevalent in the United States, where they are a growing cause of cirrhosis and …

[HTML][HTML] Nonalcoholic fatty liver disease burden–Saudi Arabia and United Arab Emirates, 2017–2030

K Alswat, AA Aljumah, FM Sanai… - Saudi Journal of …, 2018 - journals.lww.com
Materials and Methods: Models were used to estimate NAFLD and NASH disease
progression, primarily based on changes in adult prevalence rates of adult obesity and DM …

[PDF][PDF] The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

ZM Younossi, D Blissett, R Blissett, L Henry… - …, 2016 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease. There is
uncertainty around the economic burden of NAFLD. We constructed a steady‐state …

Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: data from Hong Kong

RP Tampi, VWS Wong, GLH Wong… - Hepatology …, 2020 - Wiley Online Library
Aim Non‐alcoholic steatohepatitis (NASH) is the progressive form of non‐alcoholic fatty liver
disease (NAFLD) and prevalence is rising in Asia due to increasing rates of urbanization …

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

J Li, B Zou, YH Yeo, Y Feng, X Xie, DH Lee… - The lancet …, 2019 - thelancet.com
Background Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver
disease worldwide. Asia is a large, heterogeneous area with substantial variation in …

Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis

J Liu, Y Tian, X Fu, C Mu, M Yao, Y Ni, Y Liu… - Chinese Medical …, 2022 - mednexus.org
Background: The increasing burden of non-alcoholic fatty liver disease (NAFLD) worldwide
imposes an emerging public health issue. We perform the current study to estimate the …